Cargando…
Comparison of same day diagnostic tools including Gene Xpert and unstimulated IFN-γ for the evaluation of pleural tuberculosis: a prospective cohort study
BACKGROUND: The accuracy of currently available same-day diagnostic tools (smear microscopy and conventional nucleic acid amplification tests) for pleural tuberculosis (TB) is sub-optimal. Newer technologies may offer improved detection. METHODS: Smear-microscopy, adenosine deaminase (ADA), interfer...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108018/ https://www.ncbi.nlm.nih.gov/pubmed/24708530 http://dx.doi.org/10.1186/1471-2466-14-58 |
_version_ | 1782327694187298816 |
---|---|
author | Meldau, Richard Peter, Jonny Theron, Grant Calligaro, Greg Allwood, Brian Symons, Greg Khalfey, Hoosain Ntombenhle, Gina Govender, Ureshnie Binder, Anke van Zyl-Smit, Richard Dheda, Keertan |
author_facet | Meldau, Richard Peter, Jonny Theron, Grant Calligaro, Greg Allwood, Brian Symons, Greg Khalfey, Hoosain Ntombenhle, Gina Govender, Ureshnie Binder, Anke van Zyl-Smit, Richard Dheda, Keertan |
author_sort | Meldau, Richard |
collection | PubMed |
description | BACKGROUND: The accuracy of currently available same-day diagnostic tools (smear microscopy and conventional nucleic acid amplification tests) for pleural tuberculosis (TB) is sub-optimal. Newer technologies may offer improved detection. METHODS: Smear-microscopy, adenosine deaminase (ADA), interferon gamma (IFN-γ), and Xpert MTB/RIF [using an unprocessed (1 ml) and centrifuged (~20 ml) sample] test accuracy was evaluated in pleural fluid from 103 consecutive patients with suspected pleural TB. Culture for M.tuberculosis and/or histopathology (pleural biopsy) served as the reference standard. Patients were followed prospectively to determine their diagnostic categorisation. RESULTS: Of 93 evaluable participants, 40 had definite-TB (reference positive), 5 probable-TB (not definite but treated for TB) and 48 non-TB (culture and histology negative, and not treated for TB). Xpert MTB/RIF sensitivity and specificity (95% CI) was 22.5% (12.4 - 37.6) and 98% (89.2 - 99.7), respectively, and centrifugation did not improve sensitivity (23.7%). The Xpert MTB/RIF internal positive control showed no evidence of inhibition. Biomarker specific sensitivity, specificity, PPV, and NPVs were: ADA (48.85 IU/L; rule-in cut-point) 55.3% (39.8 - 69.9), 95.2% (83.9 - 98.7), 91.4 (73.4 - 95.4), 69.7% (56.7 - 80.1); ADA (30 IU/L; clinically used cut-point) 79% (63.7 - 89), 92.7% (80.6 - 97.5), 91.0 (73.4 - 95.4), 82.7% (69.3 - 90.1); and IFN-γ (107.7 pg/ml; rule-in cut-point) 92.5% (80.2 - 97.5), 95.9% (86.1 - 98.9), 94.9% (83.2 - 98.6), 93.9% (83.5 - 97.9), respectively (IFN-γ sensitivity and NPV better than Xpert [p < 0.05] and rule-in ADA [p < 0.05]). CONCLUSION: The usefulness of Xpert MTB/RIF to diagnose pleural TB is limited by its poor sensitivity. IFN-γ is an excellent rule-in test and, compared to ADA, has significantly better sensitivity and rule-out value in a TB-endemic setting. |
format | Online Article Text |
id | pubmed-4108018 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-41080182014-07-24 Comparison of same day diagnostic tools including Gene Xpert and unstimulated IFN-γ for the evaluation of pleural tuberculosis: a prospective cohort study Meldau, Richard Peter, Jonny Theron, Grant Calligaro, Greg Allwood, Brian Symons, Greg Khalfey, Hoosain Ntombenhle, Gina Govender, Ureshnie Binder, Anke van Zyl-Smit, Richard Dheda, Keertan BMC Pulm Med Research Article BACKGROUND: The accuracy of currently available same-day diagnostic tools (smear microscopy and conventional nucleic acid amplification tests) for pleural tuberculosis (TB) is sub-optimal. Newer technologies may offer improved detection. METHODS: Smear-microscopy, adenosine deaminase (ADA), interferon gamma (IFN-γ), and Xpert MTB/RIF [using an unprocessed (1 ml) and centrifuged (~20 ml) sample] test accuracy was evaluated in pleural fluid from 103 consecutive patients with suspected pleural TB. Culture for M.tuberculosis and/or histopathology (pleural biopsy) served as the reference standard. Patients were followed prospectively to determine their diagnostic categorisation. RESULTS: Of 93 evaluable participants, 40 had definite-TB (reference positive), 5 probable-TB (not definite but treated for TB) and 48 non-TB (culture and histology negative, and not treated for TB). Xpert MTB/RIF sensitivity and specificity (95% CI) was 22.5% (12.4 - 37.6) and 98% (89.2 - 99.7), respectively, and centrifugation did not improve sensitivity (23.7%). The Xpert MTB/RIF internal positive control showed no evidence of inhibition. Biomarker specific sensitivity, specificity, PPV, and NPVs were: ADA (48.85 IU/L; rule-in cut-point) 55.3% (39.8 - 69.9), 95.2% (83.9 - 98.7), 91.4 (73.4 - 95.4), 69.7% (56.7 - 80.1); ADA (30 IU/L; clinically used cut-point) 79% (63.7 - 89), 92.7% (80.6 - 97.5), 91.0 (73.4 - 95.4), 82.7% (69.3 - 90.1); and IFN-γ (107.7 pg/ml; rule-in cut-point) 92.5% (80.2 - 97.5), 95.9% (86.1 - 98.9), 94.9% (83.2 - 98.6), 93.9% (83.5 - 97.9), respectively (IFN-γ sensitivity and NPV better than Xpert [p < 0.05] and rule-in ADA [p < 0.05]). CONCLUSION: The usefulness of Xpert MTB/RIF to diagnose pleural TB is limited by its poor sensitivity. IFN-γ is an excellent rule-in test and, compared to ADA, has significantly better sensitivity and rule-out value in a TB-endemic setting. BioMed Central 2014-04-08 /pmc/articles/PMC4108018/ /pubmed/24708530 http://dx.doi.org/10.1186/1471-2466-14-58 Text en Copyright © 2014 Meldau et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Meldau, Richard Peter, Jonny Theron, Grant Calligaro, Greg Allwood, Brian Symons, Greg Khalfey, Hoosain Ntombenhle, Gina Govender, Ureshnie Binder, Anke van Zyl-Smit, Richard Dheda, Keertan Comparison of same day diagnostic tools including Gene Xpert and unstimulated IFN-γ for the evaluation of pleural tuberculosis: a prospective cohort study |
title | Comparison of same day diagnostic tools including Gene Xpert and unstimulated IFN-γ for the evaluation of pleural tuberculosis: a prospective cohort study |
title_full | Comparison of same day diagnostic tools including Gene Xpert and unstimulated IFN-γ for the evaluation of pleural tuberculosis: a prospective cohort study |
title_fullStr | Comparison of same day diagnostic tools including Gene Xpert and unstimulated IFN-γ for the evaluation of pleural tuberculosis: a prospective cohort study |
title_full_unstemmed | Comparison of same day diagnostic tools including Gene Xpert and unstimulated IFN-γ for the evaluation of pleural tuberculosis: a prospective cohort study |
title_short | Comparison of same day diagnostic tools including Gene Xpert and unstimulated IFN-γ for the evaluation of pleural tuberculosis: a prospective cohort study |
title_sort | comparison of same day diagnostic tools including gene xpert and unstimulated ifn-γ for the evaluation of pleural tuberculosis: a prospective cohort study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108018/ https://www.ncbi.nlm.nih.gov/pubmed/24708530 http://dx.doi.org/10.1186/1471-2466-14-58 |
work_keys_str_mv | AT meldaurichard comparisonofsamedaydiagnostictoolsincludinggenexpertandunstimulatedifngfortheevaluationofpleuraltuberculosisaprospectivecohortstudy AT peterjonny comparisonofsamedaydiagnostictoolsincludinggenexpertandunstimulatedifngfortheevaluationofpleuraltuberculosisaprospectivecohortstudy AT therongrant comparisonofsamedaydiagnostictoolsincludinggenexpertandunstimulatedifngfortheevaluationofpleuraltuberculosisaprospectivecohortstudy AT calligarogreg comparisonofsamedaydiagnostictoolsincludinggenexpertandunstimulatedifngfortheevaluationofpleuraltuberculosisaprospectivecohortstudy AT allwoodbrian comparisonofsamedaydiagnostictoolsincludinggenexpertandunstimulatedifngfortheevaluationofpleuraltuberculosisaprospectivecohortstudy AT symonsgreg comparisonofsamedaydiagnostictoolsincludinggenexpertandunstimulatedifngfortheevaluationofpleuraltuberculosisaprospectivecohortstudy AT khalfeyhoosain comparisonofsamedaydiagnostictoolsincludinggenexpertandunstimulatedifngfortheevaluationofpleuraltuberculosisaprospectivecohortstudy AT ntombenhlegina comparisonofsamedaydiagnostictoolsincludinggenexpertandunstimulatedifngfortheevaluationofpleuraltuberculosisaprospectivecohortstudy AT govenderureshnie comparisonofsamedaydiagnostictoolsincludinggenexpertandunstimulatedifngfortheevaluationofpleuraltuberculosisaprospectivecohortstudy AT binderanke comparisonofsamedaydiagnostictoolsincludinggenexpertandunstimulatedifngfortheevaluationofpleuraltuberculosisaprospectivecohortstudy AT vanzylsmitrichard comparisonofsamedaydiagnostictoolsincludinggenexpertandunstimulatedifngfortheevaluationofpleuraltuberculosisaprospectivecohortstudy AT dhedakeertan comparisonofsamedaydiagnostictoolsincludinggenexpertandunstimulatedifngfortheevaluationofpleuraltuberculosisaprospectivecohortstudy |